Dupilumab Demonstrates Safety, Efficacy Across Several Type 2 Inflammatory Diseases - AJMC.com Managed Markets Network

Research presented at the European Academy of Allergy and Clinical Immunology Annual Congress show the safety and efficacy of dupilumab across several progressive diseases with underlying type 2 inflammation, including eosinophilic esophagitis (EoE), severe …

Research presented at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress demonstrate the safety and efficacy of dupilumab across several progressive diseases with underly… [+9245 chars]

full article...